Stories tagged “Growth Opportunities.”
3 stories
Eli Lilly, a US-based pharmaceutical company, has entered the Japanese market for elderly patients, with the US government approving obesity medication at $50 a month. The company's sales have increased by 48% compared to the same period last year, driven by two key produ…
Three high-yield dividend stocks, Brookfield Infrastructure, Energy Transfer, and Realty Income, are worth buying for their cash flow alone. They generate substantial cash flow to support their payouts, enabling them to reinvest in growth opportunities and drive dividend …
Atlassian Corporation: Some Falling Knives Are Not Worth Going After
Atlassian Corporation faces significant risks from AI-driven disruption, with shares down 53% in a year and persistent net losses. The company's seat-based pricing model is threatened by AI agents, while cost-cutting measures like layoffs offer limited relief against surg…